Zabriskie SPRL
Zabriskie reported total assets of 592,808 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Mar 2026).
The score of Zabriskie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +43 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zabriskie's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 9,231 € | ||||
| Equity | 549,377 € | ||||
| Cash | 23,607 € | ||||
| EBITDA | 19,972 € | ||||
| Total assets | 592,808 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 23 Mar 2026
- Year ended 30 Jun 2024filed on 19 Dec 2024
- Year ended 30 Jun 2023filed on 13 Dec 2023
- Year ended 30 Jun 2022filed on 22 Dec 2022
- Year ended 30 Jun 2021filed on 24 Jan 2022
Zabriskie's financial analysis
- Solvency92.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zabriskie
Zabriskie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.818.149
- VAT number
- BE0422818149
- Peppol
- Registered · 0208:0422818149 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 01 Jun 1982
- Registered office
- 8380 Bruges
- Latest accounts
- 2025 · filed on 23 Mar 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Zabriskie (SPRL) has been based in Bruges since 1982, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 9,231 € and equity of 549,377 €; its revenue is not published. Its solvency stands at 92.7%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Zabriskie
Companies in the same business, of comparable size and area, outside its group.
- Pharmentum Manufacture of pharmaceutical preparations Kontich · balance sheet €1.94m
- Adocs Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 717,403 €
- Alexion Services Europe Wholesale of pharmaceutical and medical goods Brussels · balance sheet 776,084 €
- LEXmedical Wholesale of pharmaceutical and medical goods Turnhout · balance sheet 554,561 €
- Cerelo Wholesale of pharmaceutical and medical goods Amel · balance sheet €1.09m
- Prochiphar Wholesale of pharmaceutical and medical goods Incourt · balance sheet €1.18m
- Ophtalmo Vision Care Wholesale of pharmaceutical and medical goods Oudenaarde · balance sheet €1.41m
- Orthomedics Wholesale of pharmaceutical and medical goods Wetteren · balance sheet €1.43m
Frequently asked questions about Zabriskie
What is the revenue of Zabriskie?
Zabriskie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Zabriskie?
In Belgium, the VAT number is the company number prefixed with BE: BE0422818149 for Zabriskie, if the company is VAT-registered. Its company number (CBE) is 0422.818.149.
Where is the registered office of Zabriskie?
According to the CBE register, the registered office of Zabriskie is in 8380 Bruges.
What is the equity of Zabriskie?
At the close of the 2025 financial year, the equity of Zabriskie amounts to 549,377 €, a solvency of 92.7% of total assets.
Who manages Zabriskie?
The register lists 1 active mandates at Zabriskie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Zabriskie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →